Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Prostate Cancer Clinical Trial

Official title:

Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01987193
• Other study ID #: UFPTI 1214 - DS01
• Status: Terminated
• Start date: July 2012
• Est. completion date: May 2018

Study information

• Verified date: May 2018
• Source: University of Florida
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is the development of noninvasive (having no direct contact) detector and electronic system that will directly measure tumor blood flow rate.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 3
• Est. completion date: May 2018
• Est. primary completion date: May 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Solid tumors in the intracranial, thoracic, or pelvic regions.

Exclusion Criteria: N/A

Related Conditions & MeSH terms

• Brain Cancer
• Brain Neoplasms
• Lung Cancer
• Prostate Cancer

Locations

Country	Name	City	State
United States	University of Florida Proton Therapy Institute	Jacksonville	Florida

Sponsors (1)

Lead Sponsor	Collaborator
University of Florida

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patients with hypoxic tumor identified by tumor blood flow measurement.		3 months